相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。All-Trans Retinoic Acid Rescues the Tumor Suppressive Role of RAR-β by Inhibiting LncHOXA10 Expression in Gastric Tumorigenesis
Chen Wang et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2021)
Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric Cancer
Takako Eguchi Nakajima et al.
CLINICAL CANCER RESEARCH (2021)
Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and Degradation
Wan Du et al.
CANCER DISCOVERY (2021)
Paraspeckle Promotes Hepatocellular Carcinoma Immune Escape by Sequestering IFNGR1 mRNA
Jie Zan et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Programmed cell death 1 as prognostic marker and therapeutic target in upper gastrointestinal cancers
Negar Khoshghamat et al.
PATHOLOGY RESEARCH AND PRACTICE (2021)
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
Kazuhiro Koikawa et al.
CELL (2021)
Burden of Gastric Cancer
Aaron P. Thrift et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Expression of programmed death ligand 1 (PD-L1) is associated with metastasis and differentiation in gastric cancer
Peng-xing He et al.
LIFE SCIENCES (2020)
NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer
Ge Qin et al.
NATURE COMMUNICATIONS (2020)
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial
Kohei Shitara et al.
JAMA ONCOLOGY (2020)
Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer
Xinjian Liu et al.
NATURE (2020)
Receptor complex and signalling pathway of the two type II IFNs, IFN-γ and IFN-γrel in mandarin fish or the so-called Chinese perch Siniperca chuatsi
Li Li et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2019)
Human CD8+CD25 +CD127 low regulatory T cells: microRNA signature and impact on TGF-β and IL-10 expression
Redouane Rouas et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer
Tingting Yang et al.
CANCER RESEARCH (2019)
Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS
Digdem Yoyen-Ermis et al.
SCIENTIFIC REPORTS (2019)
The success and the challenge of all-trans retinoic acid in the treatment of cancer
Xiaoling Ni et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)
Nuclear paraspeckles function in mediating gene regulatory and apoptotic pathways
Gabriel Pisani et al.
NON-CODING RNA RESEARCH (2019)
Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance
Jinfang Zhang et al.
NATURE (2018)
Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells
Varun Sasidharan Nair et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways
Xiaolan Lian et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Charles S. Fuchs et al.
JAMA ONCOLOGY (2018)
Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
Richard P. Tobin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells
Shingo Kozono et al.
NATURE COMMUNICATIONS (2018)
Efficiency of All-Trans Retinoic Acid on Gastric Cancer: A Narrative Literature Review
Damien Bouriez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer
Kousaku Mimura et al.
CANCER SCIENCE (2018)
Global patterns and trends in stomach cancer incidence: Age, period and birth cohort analysis
Ganfeng Luo et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Yoon-Koo Kang et al.
LANCET (2017)
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L. Burr et al.
NATURE (2017)
Cellular retinoid binding-proteins, CRBP, CRABP, FABP5: Effects on retinoid metabolism, function and related diseases
Joseph L. Napoli
PHARMACOLOGY & THERAPEUTICS (2017)
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition
Enfu Hui et al.
SCIENCE (2017)
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
Takuro Noguchi et al.
CANCER IMMUNOLOGY RESEARCH (2017)
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
Shiping Jiao et al.
CLINICAL CANCER RESEARCH (2017)
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals et al.
NATURE REVIEWS CANCER (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Immune Checkpoint Therapies in Prostate Cancer
Sangeeta Goswami et al.
CANCER JOURNAL (2016)
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Kei Muro et al.
LANCET ONCOLOGY (2016)
All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth
P. H. Nguyen et al.
ONCOGENE (2016)
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Chia-Wei Li et al.
NATURE COMMUNICATIONS (2016)
Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory
Melina Arnold et al.
EUROPEAN JOURNAL OF CANCER (2015)
Addition of all-trans-retinoic acid to omeprazole and sucralfate therapy improves the prognosis of gastric dysplasia
Jianjun Jin et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2015)
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
Shuo Wei et al.
NATURE MEDICINE (2015)
CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer
Tomoe Higuchi et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Immune Modulation in Cancer with Antibodies
David B. Page et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Continuous retinoic acid induces the differentiation of mature regulatory monocytes but fails to induce regulatory dendritic cells
Zachary C. VanGundy et al.
BMC IMMUNOLOGY (2014)
Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype
Ana Ferro et al.
EUROPEAN JOURNAL OF CANCER (2014)
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Hansjochen Wilke et al.
LANCET ONCOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Molecular Pathways: Current Role and Future Directions of the Retinoic Acid Pathway in Cancer Prevention and Treatment
Roisin M. Connolly et al.
CLINICAL CANCER RESEARCH (2013)
Biological and clinical implications of retinoic acid-responsive genes in human hepatocellular carcinoma cells
Keita Kanki et al.
JOURNAL OF HEPATOLOGY (2013)
Impaired CD4+ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients
Andreas Glaessner et al.
JOURNAL OF HEPATOLOGY (2013)
Retinoid Receptors in Gastric Cancer: Expression and Influence on Prognosis
Kong-Wang Hu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
Suzanne L. Topalian et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Retinoids, Retinoic Acid Receptors, and Cancer
Xiao-Han Tang et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T-H-17 responses
Elisabetta Volpe et al.
NATURE IMMUNOLOGY (2008)
PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθ
KA Sheppard et al.
FEBS LETTERS (2004)
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation
JM Chemnitz et al.
JOURNAL OF IMMUNOLOGY (2004)
Retinoic acid receptors and cancers
DR Soprano et al.
ANNUAL REVIEW OF NUTRITION (2004)
Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-γ receptor complex following activation by IFN-γ
J Larkin et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2000)
分享论文
